A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.
Epistemonikos ID: 8c681974347be0a9e9f2c1b00e70c4ecd3b0858a
First added on: May 21, 2024